Kelyniam Global Announces Q2 2025 Financial Results

CANTON, Conn., Aug. 11, 2025 /PRNewswire/ -- Kelyniam Global, Inc. (OTC:KLYG), a leading manufacturer of custom cranial and craniofacial implants, today announced its financial results for the half year ending on June 30, 2025.

"The Company made up significant ground from the difficult comparisons in the first quarter," said Ross Bjella, CEO of Kelyniam. "Kelyniam focused its efforts on sales execution and the 2nd quarter on quarter results improved nicely over Q1 performance.  The cranial implant market is driven by unforeseeable events and some time periods are busier than others.  Q1 this year was just a slower period and our distributors worked hard to capture as many available opportunities as possible in Q2." 

Q2 2025 Financial Highlights (compared to Q2 2024):

Total revenue of